Dr. Mathioudakis, an endocrinologist and researcher, has a strong focus on diabetes management and patient care, recognized through awards like the Baltimore Top Doc. He has contributed significantly to diabetes research, authoring over 150 publications and participating in the development of consensus guidelines in the field. His studies have offered valuable insights into using health informatics for diabetes prevention and management. After graduating from the Johns Hopkins University School of Medicine and completing his training in Internal Medicine and a fellowship in Endocrinology, Diabetes, & Metabolism, Dr. Mathioudakis joined the faculty in the Division of Endocrinology, Diabetes & Metabolism in 2012. He earned a Master of Health Science in clinical investigation in 2015 and was the Clinical Director of the Division of Endocrinology from 2016 to 2021. Currently, he co-directs the Baltimore Metropolitan Diabetes Regional Partnership, focusing on improving access to diabetes prevention and management programs. As a physician-scientist, Dr. Mathioudakis leads multiple research studies funded by the NIH, private philanthropic organizations (Helmsley Charitable Trust), non-profit organizations (Breakthrough T1D), and industry. His research focuses on the effectiveness of automated diabetes prevention programs and strategies to reduce racial disparities in diabetes technology access. He also collaborates nationally to enhance care for people with type 1 diabetes. Holding a joint appointment in the Division of Biomedical Informatics and Data Science, Dr. Mathioudakis integrates machine learning and AI in diabetes research. He has served on the national Epic Endocrinology Specialty Steering Board and chaired the Type 2 Diabetes Prognostics Working Group for the Precision Medicine Diabetes Initiative. Committed to education, he frequently lectures on endocrinology, epidemiology, and health informatics. Dr. Mathioudakis is rated as an Experienced provider by MediFind in the treatment of Diabetic Ketoacidosis. His top areas of expertise are Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Low Blood Sugar, Maturity Onset Diabetes of the Young, and Pancreaticoduodenectomy.

Mihail “Misha” Zilbermint, M.D., M.B.A., F.A.C.E. is an Associate Professor of Clinical Medicine at the Division of Endocrinology, Diabetes and Metabolism, Johns Hopkins School of Medicine. He is the Director of Endocrine Hospitalists at the Johns Hopkins Community Physicians, Chief and Director of Division of Endocrinology, Diabetes and Metabolism at Suburban Hospital in Bethesda, MD. Dr. Zilbermint is known for pioneering the Endocrine Hospitalist program at Johns Hopkins Medicine following the completion of his endocrinology fellowship at the National Institutes of Health. This consultation service is dedicated to enhancing glycemic control among hospitalized patients, effectively reducing patient stays and saving the hospital hundreds of thousands of dollars. His commitment to innovation earned his specialized diabetes team the Johns Hopkins Innovations in Clinical Care Award. Over the years, Dr. Zilbermint has been sought after for his expertise in endocrinology and diabetes, with a focus on inpatient diabetes management, diabetic ketoacidosis (DKA), Hyperosmolar Hyperglycemic State (HHS), and diabetes technology. His reputation extends nationally and internationally, as he is often invited to speak at conferences and is sought after for consultations worldwide. His extensive research interests encompass diabetes initiatives, hypoglycemia reduction, continuous glucose monitoring (CGM) systems, COVID-19 vaccines and hyperglycemia, COVID-19 and diabetes, genetic causes of hypertension, primary aldosteronism, rare adrenal tumors, and the interplay between diabetes and climate change. Dr. Zilbermint leads the JHCP Academy Clinical Excellence, which helps to recognize and promote clinical excellence about community-based clinicians. Beyond his clinical and research contributions, Dr. Zilbermint is a dedicated educator. He imparts his expertise to endocrinology fellows, hospitalists, pharmacy residents, and advanced practice providers, furthering the advancement of the medical community. CVhttps://www.hopkinsmedicine.org/-/media/profiles-support/cvs/zilbermint.pdfLinkedInhttps://www.linkedin.com/in/mishazilbermint. Dr. Zilbermint is rated as an Experienced provider by MediFind in the treatment of Diabetic Ketoacidosis. His top areas of expertise are Cushing's syndrome, Familial Hyperaldosteronism, Hyperaldosteronism, Low Blood Sugar, and Thymectomy.

Sonum Bharill is a Pediatric Endocrinologist in Baltimore, Maryland. Dr. Bharill is rated as an Experienced provider by MediFind in the treatment of Diabetic Ketoacidosis. Her top areas of expertise are Hypercalcemia, Milk-Alkali Syndrome, Diabetic Ketoacidosis, and Type 1 Diabetes (T1D).

Justin Tcheugui is an Endocrinologist in Baltimore, Maryland. Dr. Tcheugui is rated as an Experienced provider by MediFind in the treatment of Diabetic Ketoacidosis. His top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Type 1 Diabetes (T1D), and Gestational Diabetes.

Sheela N. Magge, M.D., M.S.C.E., is a pediatric endocrinologist and the director of the Division of Pediatric Endocrinology, as well as the Lawson Wilkins Endowed Chair of Pediatric Endocrinology at Johns Hopkins Children’s Center. Dr. Magge’s expertise includes the diagnosis and treatment of endocrine disorders in children and adolescents. Primary related conditions that she treats include type 2 diabetes mellitus, pre-diabetes, obesity, congenital insulin resistance syndromes, congenital lipodystrophy and polycystic ovary syndrome. Dr. Magge is an active member of the National Pediatric Endocrine Society. She is also a standing member of the National Institutes of Health (NIH) Human Studies of Diabetes and Obesity Study Section. A professor of pediatrics, Dr. Magge obtained a master’s degree in clinical epidemiology from the University of Pennsylvania. Dr. Magge is rated as an Experienced provider by MediFind in the treatment of Diabetic Ketoacidosis. Her top areas of expertise are Obesity, Type 2 Diabetes (T2D), Congenital Hyperinsulinism, and Maturity Onset Diabetes of the Young.

Maryam Movassaghian, M.D., is an endocrinologist with Johns Hopkins Community Physicians. She completed an endocrinology, diabetes and metabolism fellowship at The George Washington University Hospital where she gained further expertise in managing complex endocrine disorders. Dr. Movassaghian practices general endocrinology, including the treatment of thyroid disorders, thyroid cancer, diabetes, polycystic ovary syndrome (PCOS), obesity, pituitary and adrenal disorders, hypogonadism and osteoporosis. Dr. Movassaghian is rated as an Experienced provider by MediFind in the treatment of Diabetic Ketoacidosis. Her top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Hyperthyroidism, and Thyroid Storm.

Dr. David W. Cooke is an associate professor of pediatrics at the Johns Hopkins University School of Medicine. Dr. Cooke’s clinical activities include both a general pediatric endocrine clinic and a pediatric diabetes clinic. His clinical interests include all endocrine disorders in children and adolescents, including short stature, abnormal pubertal development, growth hormone dysregulation, thyroid disorders, hormone deficiencies, hypopituitarism, diabetes insipidis, pituitary adenoma, prolactinoma, goiter, Cushing's disease, Addison's disease, polycystic ovary syndrome, congenital adrenal hyperplasia and disorders of sexual differentiation, Turner syndrome and Klinefelter syndrome, among others. He serves as clinical director of the division of pediatric endocrinology and director of the Pediatric Endocrinology Fellowship Training Program at Johns Hopkins. He is a member of the Johns Hopkins Klinefelter Syndrome Center. Dr. Cooke completed his undergraduate studies at the Massachusetts Institute of Technology, and received his medical degree from the Duke University School of Medicine. He then completed his residency in pediatrics at The Johns Hopkins Hospital, where he also completed a fellowship in pediatric endocrinology. He has been a faculty member in the Division of Pediatric Endocrinology at the Johns Hopkins since 1993. After his fellowship, Dr. Cooke spent five years of additional research training in the Department of Biological Chemistry at Johns Hopkins, supported by an individual Physician Scientist Award from the National Institutes of Health (NIH). Dr. Cooke’s past research interest was the molecular basis of insulin resistance and obesity, with studies examining the role the adipocyte plays in these conditions. He had received research funding for these studies from the NIH and from the American Diabetes Association. Dr. Cooke is a recipient of the Johns Hopkins University School of Medicine Institute for Excellence in Education award for Outstanding Achievement in Medical and Biomedical Education. He also has been recognized as a Top Doctor by Baltimore magazine. Dr. Cooke is a member of the Society for Pediatric Research, the American Diabetes Association, the Endocrine Society and Pediatric Endocrinology Society. He is a fellow of the American Academy of Pediatrics. Dr. Cooke is rated as an Experienced provider by MediFind in the treatment of Diabetic Ketoacidosis. His top areas of expertise are Klinefelter Syndrome, Type 1 Diabetes (T1D), Precocious Puberty, and Diabetic Ketoacidosis.

Sherita Golden is an Endocrinologist in Baltimore, Maryland. Dr. Golden is rated as an Experienced provider by MediFind in the treatment of Diabetic Ketoacidosis. Her top areas of expertise are Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Obesity, and Hormone Replacement Therapy (HRT).

Shabina Ahmed, M.D., practices endocrinology at Johns Hopkins Community Physicians Downtown Bethesda. She received her medical degree from Johns Hopkins University School of Medicine, and also completed her residency in endocrinology at Johns Hopkins Medicine School of Medicine. She practices general endocrinology, including the treatment of thyroid disorders, diabetes, gender-affirming hormone therapy, PCOS, pituitary/adrenal disorders, hypogonadism and osteoporosis. Dr. Ahmed is rated as an Experienced provider by MediFind in the treatment of Diabetic Ketoacidosis. Her top areas of expertise are Osteoporosis, Postmenopausal Osteoporosis, Thyroid Cancer, and Hypothyroidism.

Dr. Scott M. Blackman is an associate professor of pediatrics at the Johns Hopkins University School of Medicine and attending at the Johns Hopkins Hospital. His areas of clinical expertise include pediatric endocrinology. Dr. Blackman cares for infants and children with all types of endocrinologic disorders, including diabetes mellitus and disorders of growth, puberty, and the thyroid and pituitary glands. He runs a multidisciplinary clinic for pediatric patients with cystic fibrosis-related diabetes (CFRD). He received his A.B. at Princeton University and his M.D. and Ph.D. degrees from the Vanderbilt University School of Medicine. He completed his internship and residency in pediatrics and fellowship in pediatric endocrinology at Johns Hopkins. Dr. Blackman has been a faculty member in pediatric endocrinology since completing his fellowship in 2007. Dr. Blackman’s research interests include identifying genetic variants responsible for endocrine abnormalities in CF including CF-related diabetes, which is seen commonly in teenagers and adults with cystic fibrosis. His long-term research goals include understanding molecular mechanisms of diabetes, such as type 1 and type 2 diabetes as well as CFRD. He is a recipient of the Gilead Research Scholars Award and has received awards from the Pediatric Endocrine Society and Cystic Fibrosis Foundation. He receives research funding from the NIH and CF Foundation. He serves as a mentor for EnVision, a national program to train endocrinologists in the care of people with CF; he serves on the Program Planning Committee for the North American CF Conference and on the editorial board of the Journal of Cystic Fibrosis. He serves on study sections for the NIH (NIDDK) and the Cystic Fibrosis Foundation. He is a member of the Society for Pediatric Research and is a U.S. News Top Doctor. Dr. Blackman is rated as an Experienced provider by MediFind in the treatment of Diabetic Ketoacidosis. His top areas of expertise are Exocrine Pancreatic Insufficiency, Type 2 Diabetes (T2D), Small for Gestational Age, and Type 1 Diabetes (T1D).

Colleen Christmas is associate professor of medicine. Practicing geriatric medicine primary care and consultative geriatric medicine, she serves as the director of the Primary Care Leadership Track and faculty in the Colleges Advising Program at the Johns Hopkins University School of Medicine. Her academic interests include medical education, professional identity formation, nutrition and exercise in the elderly. She received her medical degree from the University of Connecticut John Dempsey Hospital. Dr. Christmas is rated as an Experienced provider by MediFind in the treatment of Diabetic Ketoacidosis. Her top areas of expertise are Hypertension, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, and Diabetic Hyperglycemic Hyperosmolar Syndrome.

Dr. Donner's clinical and research interests have focused on the prevention of complications in patients with type 1 and 2 diabetes. For 6 years, he was the Associate Medical Director of the Joslin Diabetes Center affiliate at the University of Maryland, and then Medical Director from 2004 - 2010. After joining the faculty at Johns Hopkins University in 2010, his clinical and research interests became fully dedicated to diabetes. He became the Director of The Johns Hopkins Diabetes Center in 2011. He has been a clinical investigator in a number of NIH- and industry-funded diabetes research trials. Dr. Donner was a co-PI in the NIH-funded Veterans Affairs Implantable Insulin Pump Study, a Co-PI on the NIDDK-funded Diabetes Control and Complications Trial / Epidemiology of Diabetes Intervention and Complications (DCCT / EDIC) Study for 16 years, and Co-PI for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) for 7 years. Recently, he has served as PI for the Durable-response therapy Evaluation For Early or New-onset type 1 Diabetes (DEFEND-1). Dr. Donner is currently collaborating with Dr. Abdel Hamad in Immunology on preventing B-regulatory cell apoptosis using a novel monoclonal antibody targeting the presumptive apoptotic factor. This antibody prevents the development of type 1 diabetes in non obese diabetic mice. Dr. Donner is the PI for Johns Hopkins for TrialNet, a multicenter, international consortium of investigators studying ways to prevent Type 1 diabetes and preserve insulin secretion in individuals with newly diagnosed Type 1 diabetes. He is also a PI for a study investigating FIAsp, a faster-acting insulin aspart in subjects with type 1 diabetes, and is working with investigators at the Johns Hopkins School of Engineering on an implantable insulin pump which delivers insulin intravenously. Dr. Donner is rated as an Experienced provider by MediFind in the treatment of Diabetic Ketoacidosis. His top areas of expertise are Type 1 Diabetes (T1D), Diabetic Nephropathy, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young.

Rozalina Mccoy is an Endocrinologist in Baltimore, Maryland. Dr. Mccoy has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in the treatment of Diabetic Ketoacidosis. Her top areas of expertise are Low Blood Sugar, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Diabetic Hyperglycemic Hyperosmolar Syndrome.

Robert Vigersky is an Endocrinologist in Bethesda, Maryland. Dr. Vigersky is rated as an Advanced provider by MediFind in the treatment of Diabetic Ketoacidosis. His top areas of expertise are Low Blood Sugar, Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young.

Richard Akoto is a primary care provider, practicing in Family Medicine in Takoma Park, Maryland. Dr. Akoto is rated as an Advanced provider by MediFind in the treatment of Diabetic Ketoacidosis. His top areas of expertise are Diabetic Ketoacidosis, Familial Hypertension, Hypertension, and Glucocorticoid-Remediable Aldosteronism. Dr. Akoto is currently accepting new patients.

Kashif Munir is an Endocrinologist in Baltimore, Maryland. Dr. Munir is rated as an Experienced provider by MediFind in the treatment of Diabetic Ketoacidosis. His top areas of expertise are Type 2 Diabetes (T2D), Thyroid Cancer, Thyroid Storm, Pituitary Tumor, and Thyroidectomy.

Phillip Gorden is an Endocrinologist in Bethesda, Maryland. Dr. Gorden is rated as an Experienced provider by MediFind in the treatment of Diabetic Ketoacidosis. His top areas of expertise are Type B Insulin Resistance Syndrome, Congenital Generalized Lipodystrophy, Familial Hypertriglyceridemia, Congenital Hyperinsulinism, and Hormone Replacement Therapy (HRT).

Usaid Hasan is a primary care provider, practicing in Internal Medicine in Salisbury, Maryland. Dr. Hasan has been practicing medicine for over 18 years and is rated as an Experienced provider by MediFind in the treatment of Diabetic Ketoacidosis. His top areas of expertise are Sepsis, Acute Kidney Failure, Gastrointestinal Bleeding, Ureteroscopy, and Hip Replacement. Dr. Hasan is currently accepting new patients.

Salman Bhat is an Endocrinologist in Salisbury, Maryland. Dr. Bhat is rated as an Experienced provider by MediFind in the treatment of Diabetic Ketoacidosis. His top areas of expertise are Type B Insulin Resistance Syndrome, Type 2 Diabetes (T2D), Low Blood Sugar, and Thyroid Storm.

Fawad Haroon is a primary care provider, practicing in Internal Medicine in Salisbury, Maryland. Dr. Haroon is rated as an Experienced provider by MediFind in the treatment of Diabetic Ketoacidosis. His top areas of expertise are Sepsis, Chronic Inflammatory Response Syndrome (CIRS), Gastrointestinal Bleeding, and Volkmann Contracture.